BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12569612)

  • 1. Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women.
    Innos K; Horn-Ross PL
    Cancer; 2003 Feb; 97(4):1099-106. PubMed ID: 12569612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-Five Year Trends in the Incidence of Ductal Carcinoma in Situ in US Women.
    Oseni TO; Zhang B; Coopey SB; Gadd MA; Hughes KS; Chang DC
    J Am Coll Surg; 2019 Jun; 228(6):932-939. PubMed ID: 30772444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and treatment for ductal carcinoma in situ of the breast.
    Ernster VL; Barclay J; Kerlikowske K; Grady D; Henderson C
    JAMA; 1996 Mar; 275(12):913-8. PubMed ID: 8598618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.
    Hausauer AK; Keegan TH; Chang ET; Clarke CA
    Breast Cancer Res; 2007; 9(6):R90. PubMed ID: 18162138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in incidence and treatment for ductal carcinoma in situ in Hispanic, American Indian, and non-Hispanic white women in New Mexico, 1973-1994.
    Adams-Cameron M; Gilliland FD; Hunt WC; Key CR
    Cancer; 1999 Mar; 85(5):1084-90. PubMed ID: 10091792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of Ductal Carcinoma
    Ryser MD; Hendrix LH; Worni M; Liu Y; Hyslop T; Hwang ES
    Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1316-1323. PubMed ID: 31186262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.
    Bailes AA; Kuerer HM; Lari SA; Jones LA; Brewster AM
    Cancer; 2013 Jan; 119(1):150-7. PubMed ID: 22736444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase.
    Hou N; Huo D
    Breast Cancer Res Treat; 2013 Apr; 138(2):633-41. PubMed ID: 23446808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in mortality-to-incidence ratios by race/ethnicity for female breast cancer in New York City, 2002-2016.
    Nobel TB; Asumeng CK; Jasek J; Van Beck KC; Mathur R; Qiao B; Brown JJ
    Cancer Med; 2020 Nov; 9(21):8226-8234. PubMed ID: 33006431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparities in risk of second breast tumors after ductal carcinoma in situ.
    Liu Y; Colditz GA; Gehlert S; Goodman M
    Breast Cancer Res Treat; 2014 Nov; 148(1):163-73. PubMed ID: 25261293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.
    Taparra K; Fukui J; Killeen J; Sumida K; Loo LWM; Hernandez BY
    JAMA Netw Open; 2021 Oct; 4(10):e2128977. PubMed ID: 34668945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ.
    Liu Y; West R; Weber JD; Colditz GA
    Cancer; 2019 Sep; 125(18):3225-3233. PubMed ID: 31120565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
    Innos K; Horn-Ross PL
    Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Birth hospital and racial and ethnic differences in severe maternal morbidity in the state of California.
    Mujahid MS; Kan P; Leonard SA; Hailu EM; Wall-Wieler E; Abrams B; Main E; Profit J; Carmichael SL
    Am J Obstet Gynecol; 2021 Feb; 224(2):219.e1-219.e15. PubMed ID: 32798461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival.
    Stafford HS; Saltzstein SL; Shimasaki S; Sanders C; Downs TM; Sadler GR
    J Urol; 2008 May; 179(5):1704-8. PubMed ID: 18343443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence Trends of Breast Cancer Molecular Subtypes by Age and Race/Ethnicity in the US From 2010 to 2016.
    Acheampong T; Kehm RD; Terry MB; Argov EL; Tehranifar P
    JAMA Netw Open; 2020 Aug; 3(8):e2013226. PubMed ID: 32804214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disparities in breast cancer incidence across racial/ethnic strata and socioeconomic status: a systematic review.
    Vainshtein J
    J Natl Med Assoc; 2008 Jul; 100(7):833-9. PubMed ID: 18672561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial/ethnic differences in use and duration of adjuvant hormonal therapy for breast cancer in the women's health initiative.
    Livaudais JC; Lacroix A; Chlebowski RT; Li CI; Habel LA; Simon MS; Thompson B; Erwin DO; Hubbell FA; Coronado GD
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):365-73. PubMed ID: 23275187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.
    Madubata CC; Liu Y; Goodman MS; Yun S; Yu J; Lian M; Colditz GA
    Breast Cancer Res Treat; 2016 Dec; 160(3):563-572. PubMed ID: 27771840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.